Related Experiment Video
Updated: Jun 27, 2025
Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
Published on: December 16, 2021
Relationship between arginine methylation and vascular calcification
Chen Chen1, Yuanyuan Ding2, Qun Huang1
1Department of Nephrology, Shengjing Hospital, China Medical University, China.
Insights
Arginine methylation regulates vascular calcification (VC) in chronic kidney disease patients on maintenance hemodialysis. This epigenetic process impacts vascular smooth muscle cell transdifferentiation and cardiovascular disease risk.
Area of Science:
- Nephrology
- Cardiovascular Biology
- Epigenetics
Background:
- Vascular calcification (VC) is a key predictor of cardiovascular disease (CVD) and mortality in maintenance hemodialysis (MHD) patients with chronic kidney disease (CKD).
- Vascular smooth muscle cells (VSMCs) undergo osteogenic transdifferentiation, driven by oxidative stress and mineral imbalance, leading to VC.
- Post-translational modifications, including arginine methylation, are emerging regulators of VC, similar to their role in osteoblast differentiation.
Purpose of the Study:
- To propose that arginine methylation is a critical regulator of vascular calcification (VC) in chronic kidney disease (CKD).
- To elucidate the molecular mechanisms by which arginine methylation influences VC through various signaling pathways.
Main Methods:
- Review and synthesis of existing literature on vascular calcification, epigenetics, and arginine methylation in CKD.
- Analysis of proposed signaling pathways (NF-κB, WNT, AKT/PI3K, TGF-β/BMP/SMAD, IL-6/STAT3) involved in VC regulation.
- Examination of arginine methylation's potential impact on VC-related factors, oxidative stress, and endoplasmic reticulum stress.
Main Results:
- Arginine methylation is proposed to regulate VSMC osteogenic transdifferentiation, a key process in VC.
- Arginine methylation influences multiple signaling pathways implicated in VC pathogenesis.
- This epigenetic modification may also modulate VC-associated calcification factors and cellular stress responses.
Conclusions:
- Arginine methylation plays a significant role in regulating vascular calcification (VC) in CKD.
- Understanding these regulatory mechanisms offers potential therapeutic targets for preventing VC and CVD in MHD patients.
- Further research into arginine methylation's role in VC is warranted.
Abstract:
In patients on maintenance hemodialysis (MHD), vascular calcification (VC) is an independent predictor of cardiovascular disease (CVD), which is the primary cause of death in chronic kidney disease (CKD). The main component of VC in CKD is the vascular smooth muscle cells (VSMCs). VC is an ordered, dynamic activity. Under the stresses of oxidative stress and calcium-‑phosphorus imbalance, VSMCs undergo osteogenic phenotypic transdifferentiation, which promotes the formation of VC. In addition to traditional epigenetics like RNA and DNA control, post-translational modifications have been discovered to be involved in the regulation of VC in recent years. It has been reported that the process of osteoblast differentiation is impacted by catalytic histone or non-histone arginine methylation. Its function in the osteogenic process is comparable to that of VC. Thus, we propose that arginine methylation regulates VC via many signaling pathways, including as NF-B, WNT, AKT/PI3K, TGF-/BMP/SMAD, and IL-6/STAT3. It might also regulate the VC-related calcification regulatory factors, oxidative stress, and endoplasmic reticulum stress. Consequently, we propose that arginine methylation regulates the calcification of the arteries and outline the regulatory mechanisms involved.
